SMART approach lowers risk of asthma exacerbations


eMediNexus    22 March 2018

Adopting the SMART (single maintenance and reliever therapy) treatment approach of using an inhaled corticosteroid (ICS) and the long-acting β2-agonist formoterol significantly lowers the risk of asthma exacerbations, according to a systematic review and meta-analysis reported in JAMA.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.